Thermalin Diabetes(Opens in a new window)(Opens in a new window) is picking up steam – and funding – as it develops a more concentrated and faster-acting version of insulin.The Boston and Cleveland-based company just raised $5.9 million from private investors in the first tranche of a Series B round. To date, it has raised about $15 million […]
Everyone likes to talk about funding for digital health – Y Combinator is doing biotech(Opens in a new window) now! Andreesen Horowitz(Opens in a new window) gets into health tech! Deals and dollars look great(Opens in a new window) in Q1 2014!It’s not as easy to make cheery slide decks about funding for the rest […]
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Thanks to a new three-year, $1 million grant, a group of researchers at Case Western Reserve University are continuing to develop and test a form of glucose-responsive insulin that may someday be able to reduce the risk of dangerous hypoglycemic episodes in people with type 1 diabetes.The insulin is being developed in the lab of […]
(Opens in a new window)Next-generation insulin developer Thermalin Diabetes(Opens in a new window) has received a $4.5 million grant from the National Institutes of Health to continue development of its insulin analogs.The grant is expected to fund Cleveland-based Thermalin through the filing of an investigational new drug(Opens in a new window) (IND) application for a […]
(Opens in a new window)Next-generation insulin developer Thermalin Diabetes(Opens in a new window) is targeting an $8 million series B round of investment that would fund the first in-human studies of its insulin analogs.A successful clinical trial — though a long way off for the Cleveland-based company — would represent a huge milestone for Thermalin. […]
(Opens in a new window)Next-generation insulin developer Thermalin Diabetes(Opens in a new window) has closed a $2.85 million Series A investment round.The Cleveland-based startup plans to use the funding to step up production of its insulin analogs(Opens in a new window) — new proteins engineered to act like insulin in the body — and continue […]
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Rick Berenson is charged with developing the business of one of Northeast Ohio's most promising startups -- Thermalin Diabetes, which is developing new forms of insulin called "insulin analogs." The company is offering diabetes without the insulin side effects: it will last longer and have less cancer risk.
Thermalin Diabetes Inc. has been granted by Case Western Reserve University an exclusive license for a portfolio of insulin analogs, proteins engineered to act like insulin in the body.
Startup Thermalin Diabetes Inc. has raised $1.9 million in equity to commercialize new forms of insulin developed at Case Western Reserve University, according to a regulatory filing.
Thermalin Diabetes Inc.(Opens in a new window), the Cleveland start-up that is developing new forms of insulin, has received a $250,000 investment commitment from JumpStart Ventures(Opens in a new window) on the way to a Series A fundraising likely to be completed by the end of May.“It’s the first piece of what I think will […]
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
Case Western Reserve University and University Hospitals Case Medical Center will participate in a consortium of national experts investigating why unexplained anemia is common in older adults. The consortium, called the Partnership for Anemia: Clinical and Translational Trials in the Elderly, is the result of a $16 million grant awarded by the National Institute on Aging.